Found: 153
Select item for more details and to access through your institution.
Gene expression and chromatin conformation of microglia in virally suppressed people with HIV.
- Published in:
- Life Science Alliance, 2024, v. 7, n. 10, p. 1, doi. 10.26508/lsa.202402736
- By:
- Publication type:
- Article
Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 7, p. 423, doi. 10.1111/jvh.13928
- By:
- Publication type:
- Article
Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 19, p. 1670, doi. 10.1001/jama.2024.4800
- By:
- Publication type:
- Article
Response to Drs de Grooth and Parienti.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1596, doi. 10.1093/infdis/jiae053
- By:
- Publication type:
- Article
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 4, p. 1, doi. 10.1371/journal.ppat.1011680
- By:
- Publication type:
- Article
Managing HIV During the COVID-19 Pandemic: A Study of Help-Seeking Behaviors on a Social Media Forum.
- Published in:
- AIDS & Behavior, 2024, v. 28, n. 4, p. 1166, doi. 10.1007/s10461-023-04134-9
- By:
- Publication type:
- Article
Study protocol: Project 2VIDA! SARS-CoV-2 vaccine intervention delivery for adults in Southern California.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1291332
- By:
- Publication type:
- Article
Regulate Artificial Intelligence in Health Care by Prioritizing Patient Outcomes.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 8, p. 639, doi. 10.1001/jama.2024.0549
- By:
- Publication type:
- Article
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 11, p. 4805, doi. 10.1007/s12325-023-02618-7
- By:
- Publication type:
- Article
Machine-Made Empathy? Why Medicine Still Needs Humans—Reply.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 11, p. 1279, doi. 10.1001/jamainternmed.2023.4392
- By:
- Publication type:
- Article
HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 11, p. 2171, doi. 10.3390/v15112171
- By:
- Publication type:
- Article
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 941, doi. 10.1093/cid/ciad342
- By:
- Publication type:
- Article
Identification of system-level features in HIV migration within a host.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291367
- By:
- Publication type:
- Article
#MedEd: Medical Education and Knowledge Translation on Social Media.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 10, p. 909, doi. 10.1001/jama.2023.12465
- By:
- Publication type:
- Article
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S77, doi. 10.1093/infdis/jiad246
- By:
- Publication type:
- Article
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S83, doi. 10.1093/infdis/jiad300
- By:
- Publication type:
- Article
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S92, doi. 10.1093/infdis/jiad209
- By:
- Publication type:
- Article
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S101, doi. 10.1093/infdis/jiad285
- By:
- Publication type:
- Article
Immune Status and SARS-CoV-2 Viral Dynamics.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S111, doi. 10.1093/infdis/jiad200
- By:
- Publication type:
- Article
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S117, doi. 10.1093/infdis/jiad287
- By:
- Publication type:
- Article
Long COVID After Bamlanivimab Treatment.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S126, doi. 10.1093/infdis/jiad286
- By:
- Publication type:
- Article
Variant-Specific Viral Kinetics in Acute COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S136, doi. 10.1093/infdis/jiad314
- By:
- Publication type:
- Article
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 2, p. 133, doi. 10.1093/infdis/jiad013
- By:
- Publication type:
- Article
Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies.
- Published in:
- PLoS Pathogens, 2023, v. 18, n. 6, p. 1, doi. 10.1371/journal.ppat.1011416
- By:
- Publication type:
- Article
Evaluating Artificial Intelligence Responses to Public Health Questions.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2317517, doi. 10.1001/jamanetworkopen.2023.17517
- By:
- Publication type:
- Article
Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 6, p. 589, doi. 10.1001/jamainternmed.2023.1838
- By:
- Publication type:
- Article
CHARACTERIZATION OF SINGLE VERSUS DUAL ACTIVE mAB AGAINST SARS-CoV-2.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 69
- By:
- Publication type:
- Article
SAFETY AND EFFICACY OF INHALED INTERFERON-β1A (SNG001) IN OUTPATIENTS WITH COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 69
- By:
- Publication type:
- Article
SYMPTOM AND VIRAL REBOUND IN UNTREATED COVID-19 INFECTION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 70
- By:
- Publication type:
- Article
PLASMA ANTIBODY AND N ANTIGEN STATUS PREDICT OUTCOMES IN OUTPATIENTS WITH COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 114
- By:
- Publication type:
- Article
NK CELL BIOMARKERS THAT PREDICT TIME-TO-REBOUND IN HIV+ INDIVIDUALS UNDERGOING ATI.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 134
- By:
- Publication type:
- Article
CD103 EXPRESSION ON CD8 T CELLS PREDICTS LONGER TIME REBOUND OF HIV AFTER ATI.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 151
- By:
- Publication type:
- Article
PREDICTORS OF HIV REBOUND AFTER INTERRUPTION OF ART STARTED DURING PRIMARY INFECTION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 154
- By:
- Publication type:
- Article
SYSTEMIC INFLAMMATION, GUT DYSBIOSIS AND GUT MICROBIOME IMPACT HIV MIGRATION DYNAMICS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 166
- By:
- Publication type:
- Article
TIXAGEVIMAB/CILGAVIMAB IM AND IV FOR COVID-19: A RANDOMIZED CONTROLLED ACTIV-2 TRIAL.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 225
- By:
- Publication type:
- Article
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 3, p. 348, doi. 10.7326/M22-2381
- By:
- Publication type:
- Article
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 4, p. 734, doi. 10.1093/cid/ciac818
- By:
- Publication type:
- Article
Virologic and Immunologic Characterization of Coronavirus Disease 2019 Recrudescence After Nirmatrelvir/Ritonavir Treatment.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e530, doi. 10.1093/cid/ciac496
- By:
- Publication type:
- Article
Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD).
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-022-00535-x
- By:
- Publication type:
- Article
Natural killer cells for antiviral therapy.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 677, p. 1, doi. 10.1126/scitranslmed.abl5278
- By:
- Publication type:
- Article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Cocirculation and replacement of SARS-CoV-2 variants in crowded settings and marginalized populations along the US-Mexico border.
- Published in:
- Salud Pública de México, 2023, v. 65, n. 1, p. 10, doi. 10.21149/13980
- By:
- Publication type:
- Article
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program.
- Published in:
- Current HIV/AIDS Reports, 2022, v. 19, n. 6, p. 566, doi. 10.1007/s11904-022-00628-8
- By:
- Publication type:
- Article
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 11, p. 1, doi. 10.1093/ofid/ofac618
- By:
- Publication type:
- Article
SARS-CoV-2 Omicron Variant of Concern: Everything You Wanted to Know about Omicron but Were Afraid to Ask.
- Published in:
- Yonsei Medical Journal, 2022, v. 63, n. 11, p. 977, doi. 10.3349/ymj.2022.0383
- By:
- Publication type:
- Article
The rapidly evolving monkeypox epidemic: A call to action to leave no one behind.
- Published in:
- PLoS Medicine, 2022, v. 19, n. 10, p. 1, doi. 10.1371/journal.pmed.1004128
- By:
- Publication type:
- Article
Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2238867, doi. 10.1001/jamanetworkopen.2022.38867
- By:
- Publication type:
- Article
Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue Reservoirs.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 8, p. 1342, doi. 10.1093/cid/ciac164
- By:
- Publication type:
- Article
Comparative Dynamics of Delta and Omicron SARS-CoV-2 Variants across and between California and Mexico.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/v14071494
- By:
- Publication type:
- Article
Characterizing genetic transmission networks among newly diagnosed HIV-1 infected individuals in eastern China: 2012–2016.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269973
- By:
- Publication type:
- Article